CVI Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

CVI Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-142,035	Closed	-$2.48M	–	621
2020 Q4	$2.48M	Buy	+142,035	New	+$2.79M	0.46%	63

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

CVI Holdings's MIRM Position: Q1 2021 in Review

CVI Holdings sold out of Mirum Pharmaceuticals (MIRM) in Q1 2021, closing a stake of 142,035 shares — an estimated $2.48M sold.

CVI Holdings first reported a position in MIRM in Q4 2020 and held it in 1 quarter. The position peaked at $2.48M in Q4 2020. 61 funds tracked by Wall St. Rank hold MIRM as of Q1 2021.

CVI Holdings reported no remaining Mirum Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
CVI Holdings sold 142,035 Mirum Pharmaceuticals shares in Q1 2021, an estimated $2.48M.
CVI Holdings first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 1 quarter.
CVI Holdings's Mirum Pharmaceuticals position peaked at $2.48M in Q4 2020.
61 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2021.

Based on CVI Holdings's 13F filing for Q1 2021, filed 17 May 2021.